Effect of Propranolol, Procainamide, and Lidocaine on Ventricular Automaticity and Reentry in Experimental Myocardial Infarction
Overview
Authors
Affiliations
Reappraisal of lignocaine therapy in management of myocardial infarction.
PENTECOST B, De Giovanni J, Lamb P, Cadigan P, Evemy K, Flint E Br Heart J. 1981; 45(1):42-7.
PMID: 7459164 PMC: 482487. DOI: 10.1136/hrt.45.1.42.
Kertes P, Hunt D Br Heart J. 1984; 52(3):241-7.
PMID: 6380549 PMC: 481620. DOI: 10.1136/hrt.52.3.241.
Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.
Denaro C, Benowitz N Med Toxicol Adverse Drug Exp. 1989; 4(6):412-28.
PMID: 2513464 DOI: 10.1007/BF03259923.
Karlsson E Br Heart J. 1975; 37(7):731-40.
PMID: 1098684 PMC: 482865. DOI: 10.1136/hrt.37.7.731.
Observations on intravenous administration of lignocaine in patients with myocardial infarction.
Campbell N, Kelly J, Adgey A, McDevitt D, PANTRIDGE J Br Heart J. 1978; 40(12):1371-5.
PMID: 737094 PMC: 483581. DOI: 10.1136/hrt.40.12.1371.